Teprenone
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 6809-52-5 |
| ATC code | None |
| PubChem | CID 5282199 |
| UNII | S8S8451A4O |
| KEGG | D01827 |
| Chemical data | |
| Formula | C23H38O |
| Mol. mass | 330.547 g/mol |
| |
|
Teprenone (or geranylgeranylacetone) is a pharmaceutical drug used for the treatment of gastric ulcers.[1]
In Japan it is sold under the brand name Selbex (セルベックス).
[edit] References
- ^ Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879. http://www.anesthesia-analgesia.org/cgi/pmidlookup?view=long&pmid=18713879.
|
||||||||||||||||||||||
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |